Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

SIINFEKL, an exact peptide

Exact text → Patent proteins

Download as Excel

Every list and the search record, one sheet each.

Query
SIINFEKL · 8 lettersSIINFEKL
Set
Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
771 sequences, 2,028 publications, 1,357 families

Charts

Identity against coverage

771 hits by identity and query coverage. 771 with a date.

Has a date90909292949496969898100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%771771
Hits by query coverage
BandHas a dateAll
100%771771

Hits by year

1,357 families by year of first publication, 1994 to 2026.

Has a dateFamilies05010015019941997200020032006200920122015201820212024
Show table
Families by year of first publication
YearHas a dateAll
199411
199511
199855
199944
200022
20012323
20021414
20031717
20041515
20053737
20063131
20072929
20082828
20093232
20103232
20114848
20123535
20134646
20144242
20156161
20166969
20177979
20188282
20198686
20208080
20218787
20226666
20239494
2024102102
20258181
20262828

Where hits align on the query

The top 20 hits on SIINFEKL, a query of 8 amino acids: 20 cover the whole query, none differs from it.

Aligned partDiffers from the querySIINFEKL · 8 amino acids12468SIINFEKLAAE13361.1AAA94863.1AAC86077.1AAO94511.1AAO94501.1CS072231.1CS072222.1AZK27020.1CS072221.1ABH87918.1ABH87917.1ABH87919.1AX288232.1AX288234.1AX288233.1AX288231.1AX288237.1AX288235.1AX288236.1AQN09305.1
Show table
The top 20 hits on SIINFEKL, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atX at
AAE13361.118100.0%NoneNoneNone
AAA94863.118100.0%NoneNoneNone
AAC86077.118100.0%NoneNoneNone
AAO94511.118100.0%NoneNoneNone
AAO94501.118100.0%NoneNoneNone
CS072231.118100.0%NoneNoneNone
CS072222.118100.0%NoneNoneNone
AZK27020.118100.0%NoneNoneNone
CS072221.118100.0%NoneNoneNone
ABH87918.118100.0%NoneNoneNone
ABH87917.118100.0%NoneNoneNone
ABH87919.118100.0%NoneNoneNone
AX288232.118100.0%NoneNoneNone
AX288234.118100.0%NoneNoneNone
AX288233.118100.0%NoneNoneNone
AX288231.118100.0%NoneNoneNone
AX288237.118100.0%NoneNoneNone
AX288235.118100.0%NoneNoneNone
AX288236.118100.0%NoneNoneNone
AQN09305.118100.0%NoneNoneNone

Patents 2K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

2,028 publications in 1,357 families match these filters.

  1. EP 1981534-A22008-10-22

    Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells

    MED COLLEGE GEORGIA RES INST

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  2. JP 2008543301-A2008-12-04

    AGENTS AND METHODS BASED ON THE USE OF EDA DOMAIN OF FIBRONECTIN

    PROYECTO DE BIOMEDICINA CIMA S L

    Best alignment

    Query 1 to 8, hit 95 to 102. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit    95 SIINFEKL 102
    

    8 of 8 identical, no gaps.

  3. EP 1998801-A22008-12-10

    Tem8 as an adjuvant and uses thereof

    SLOAN KETTERING INST CANCER

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  4. JP 2008544760-A2008-12-11

    Obtention of food- or auto-antigen specific Tr1 cells from a leukocyte or PBMC population

    Institut National de la Sante et de la Recherche Medicale

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, EP 05291429.8.

  5. JP 2008545180-A2008-12-11

    System and Method for Automated Selection of T-Cell Epitopes

    Merck and Co Inc

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  6. JP 2008308474-A2008-12-25

    Preparating method for antigenic oligopeptide

    NITTO DENKO CORPORATION

    Best alignment

    Query 1 to 8, hit 2 to 9. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   2 SIINFEKL 9
    

    8 of 8 identical, no gaps.

  7. JP 2008546775-A2008-12-25

    MODULATION OF NEGATIVE IMMUNE REGULATORS AND APPLICATIONS FOR IMMUNOTHERAPY

    Baylor College of Medicine

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  8. Immune modulation via c-type lectin

    Sancho-Madrid, David (GB)

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  9. EP 2024538-A22009-02-18

    Compositions for and methods of identifying antigens

    HARVARD COLLEGE

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  10. US 7498046-A2009-03-03

    Composition for inducing immune response comprising inverted microsomes

    Queen Mary & Westfield College

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  11. US 7501119-A2009-03-10

    Methods and molecules for modulating an immune response

    Mayo Foundation for Medical Education and Research

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  12. US 7501125-A2009-03-10

    Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent

    Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  13. JP 2009079048-A2009-04-16

    Modified Peptides YY and Conjugates Thereof

    ConjuChem Biotechnologies Inc

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  14. Increase of immune response and targeting by antigens and/or drug linkage

    Wittycell (FR)

    Best alignment

    Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    9 SIINFEKL 16
    

    8 of 8 identical, no gaps.

  15. Vaccine comprising Monocyte or immature myeloid cells(IMC) which was loaded with the ligand of natural killer T cell and antigen

    Seoul National University Industry Foundation

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  16. US 7538083-A2009-05-26

    Compositions and methods for the potentiation of immune responses against target antigens

    Intercell AG

    Best alignment

    Query 1 to 8, hit 12 to 19. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   12 SIINFEKL 19
    

    8 of 8 identical, no gaps.

  17. EP 2062592-A12009-05-27

    System for delivery into a XCR1 positive cell and uses thereof

    BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Prasidenten (DE)

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, EP 07022471.2.

  18. JP 2009520772-A2009-05-28

    NOVEL T-HELPER ANTIGENIC DETERMINANT (THD) PEPTIDES

    PROYECTO DE BIOMEDICINA CIMA S L

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  19. System for delivery into a xcr1 positive cell and uses thereof

    Bundesrepublik Deutschland Letztvertreten Durch Das Robert Koch- Institut (DE)

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  20. Peptides that can bind to scurfin and uses thereof

    Proyecto de Biomedicina Cima, S.L. (ES)

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  21. Functionalised biochips for spr-ms coupling

    Centre National de la Recherche Scientifique (FR)

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  22. EP 2069381-A22009-06-17

    Agents and methods to elicit anti-tumor immune response

    UNIV COLUMBIA

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  23. Method for preparing protein conjugates

    GlaxoSmithKline Biologicals S.A. (BE)

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  24. EP 2076272-A22009-07-08

    Generating an immune response by inducing cd40 and pattern recognition receptors

    BAYLOR COLLEGE MEDICINE

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  25. Immunostimulatory combinations of tlr ligands and methods of use

    Department of Health and Human Services (US)

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  26. US 7563882-A2009-07-21

    Polynucleotides encoding antibodies that bind to the C35 polypeptide

    University of Rochester

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  27. JP 2009528065-A2009-08-06

    ENGINEERED LISTERIA AND METHODS OF USE THEREOF

    Anza Therapeutics Inc

    Best alignment

    Query 1 to 8, hit 142 to 149. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   142 SIINFEKL 149
    

    8 of 8 identical, no gaps.

  28. EP 2097927-A12009-09-09

    Systems and methods for cmos-compatible silicon nano-wire sensors with biochemical and cellular interfaces

    UNIV YALE

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  29. US 7589174-A2009-09-15

    GRP94-based compositions and methods of use thereof

    The Children's Hospital of Philadelphia and The University of Chicago

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  30. EP 2100901-A12009-09-16

    Modified Insulin and conjugates thereof

    ConjuChem Biotechnologies Inc. (CA)

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  31. US 7595060-A2009-09-29

    Yeast-antigen compositions methods of making the same

    GlobeImmune, Inc. and The Regents of the University of Colorado

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  32. JP 2009535059-A2009-10-01

    CD40 AGONIST ANTIBODY/TYPE 1 INTERFERON SYNERGISTIC ADJUVANT COMBINATION, CONJUGATES CONTAINING AND USE THEREOF AS A THERAPEUTIC TO ENHANCE CELLULAR IMMUNITY

    ROSS KEDL,PHILLIP J SANCHEZ,CATHERINE HALUSZCZAK

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 60/796867.

  33. THERAPEUTIC AGENT FOR CANCER

    THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  34. EP 2114416-A12009-11-11

    Method of inducing an immune response

    UNIV QUEENSLAND

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  35. US 7622273-A2009-11-24

    Method for chemical and enzymatic treatment of posttranslationally modified proteins bound to a protein chip

    Best alignment

    Query 1 to 8, hit 257 to 264. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   257 SIINFEKL 264
    

    8 of 8 identical, no gaps.

  36. JP 2009273377-A2009-11-26

    Method for selecting candidate peptides which bind to MHC class I molecules and express on the cancer cell surface

    MEDICAL AND BIOLOGICAL LABORATORIES CO LTD,KEIO UNIVERSITY

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  37. US 7625567-A2009-12-01

    Induction of immune responses to isoaspartyl-modified antigens

    Yale University

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  38. US 7632514-B22009-12-15

    Universal carrier for targeting molecules to Gb3 receptor expressing cells

    Institute Curie, Centre National de la Recherche Scientifque, Institut National de la Sante et de la Recherche Medicale and Universite Pierre et Marie Curie (Paris VI)

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  39. JP 2009544291-A2009-12-17

    A CANCER VACCINE COMPRISING A MUCIN 1 (MUC1) T CELL EPITOPE-DERIVED PEPTIDE

    4G VACCINES PTY LTD

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  40. EP 2139913-A22010-01-06

    Inducing immune-mediated tumor cell death

    MAYO FOUNDATION

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  41. US 7691393-B22010-04-06

    Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof

    Anza Therapeutics, Inc.

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  42. US 7695725-B22010-04-13

    Modified free-living microbes, vaccine compositions and methods of use thereof

    Aduro Biotech

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 192 to 199. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   192 SIINFEKL 199
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  43. Recombinant protein bodies as immunogen-specific adjuvants

    ERA Biotech, S.A. (ES)

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  44. US 7705199-B22010-04-27

    Compositions and methods for treatment of autoimmune and related diseases

    The Scripps Research Institute

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  45. EP 2178548-A12010-04-28

    Survivin peptides as cancer vaccines

    HEALTH RESEARCH INC

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  46. WO 2010050190-A2010-05-06

    Molecular markers for cancer stem cells

    Japan Science and Technology Agency,Sapporo Medical University

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  47. EP 2185577-A22010-05-19

    Chlamydia antigens

    HARVARD COLLEGE

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  48. Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer

    LUDWIG INSTITUTE FOR CANCER RESEARCH (US)

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  49. WO 2010061930-A2010-06-03

    Immunotherapy by using allogenic cell capable of co-expressing target antigen and CD1d

    RIKEN

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  50. Use of phenol-soluble modulins for vaccine development

    Institut Pasteur (FR)

    Best alignment

    Query 1 to 8, hit 23 to 30. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   23 SIINFEKL 30
    

    8 of 8 identical, no gaps.